chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received 2nd dose of the vaccine on 7/24/21.  On 7/30/21, I developed constant tingling in hands, feet, and legs around 11am.  The sensation became more intense by approximately 3pm.  I contacted by Primary Care Physician and informed him of my symptoms.  He ordered Gabapentin 1-2 capsules twice a day, which I started that evening.  That night I developed sharp and intense pains in my feet, legs, and hands.  On 8/2/21, I saw my PCP and informed him that the tingling had progressed to extreme pain.  He then increased the Gabapentin to three times a day.  Within 4-5 days, the pain and tingling started to subside. By 8/9/21, the symptoms had resolved.  I discontinued the medication on 8/15/21.  Since then, I have only had one episode of sharp pain to my right foot which lasted about 5 minutes and subsided.
I had mild flu symtoms following my 2nd vaccination.    I had a rash all over my back that looked like chicken pox.  Benedryl eased the red marks.  I'm fine now.  I'm only reporting this to give information about 2nd Moderna vaccine and possible side effects.
The patient, as per his daughter's account was not well after few hours of the vaccine and went into the hospital then later to another hospital during this few days  after the vaccine he suffered multiple organ failure  and  he  died after few days
No additional AEs; a patient who is currently 9 weeks pregnant was administered MMR II/the patient is currently 9 weeks pregnant and was more than likely pregnant at the time of MMR II administration; This spontaneous prospective pregnancy report as received from a registered nurse refers to a 29-year-old female patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On an unknown date in February 2021, the pregnant patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (exact dose, route of administration, anatomical location, lot # and expiration date were not reported) for prophylaxis. At the time of the report, the patient was 9 weeks pregnant, the pregnancy outcome was pending and the fetal outcome was unknown.
This spontaneous report as received from a physician via a company representative refers to a 1 year old female patient with no pertinent medical history. On an unknown date, reported as second week of September (year not reported), the patient was vaccinated with a dose of M-M-R II (dose reported as required dosing, route and lot number were not reported) as a state required vaccine. Concomitant medications were not specified. On an unkonwn date, the patient experienced fever, red bumpy rash on the trunk of her body, vomited and fussiness while using M-M-R II. The patient sought medical attention. Treatment (unspecified) was given for the adverse events. The outcome of fever, red bumpy rash on the trunk of her body, vomited and fussiness was unknown. The relatedness between the events and M-M-R II was not reported. Additional information has been requested.
"I noticed a swelling, redness, itching at the site of the vaccination. It was getting bigger as the day went by....I am still feeling some pain, and itching (2/21/2019 @1019 a.m.)."
Muscle aches / Joint pain and soreness. Headache  Fatigue/ lethargic
Minor rash and itchiness behind leg and arm joints which  progressed to severe rash and itchiness after several weeks; extending 5-6 inches from initial site. Physician  diagnosed as eczema and treating with  triamcinolone acetate 0.1% cream twice a day for 14 days. Symptoms improving, currently at 3rd day of treatment.
After first vaccination (Hepatitis B) - Colic, sleeplessness, irritability. Same following next several vaccinations, followed by cognitive skill delays, speech delays, social delays and restrictive interests. Increased delays following last vaccinations given on 10/11/2006. Finally diagnosed with Autism at 23 months old. Course of treatment was ABA, OT and Speech therapy, along with GFCF diet and other biomedical treatments.  8/21/09 Psych/Autism consultation records received DOS 9/12/07. Assessment: Pervasive Developmental Disorder, Not Otherwise Specified. Parents are concerned about language delay. Does not respond to name or understand what is said to her. Impaired peer relationships, social and emotional reciprocity. Spins in circles. Temper tantrums. She presents with 3 cafe' au lait birthmarks.
Mid to late August, I experienced severe fatigue and nausea. The next day I had a sore throat, the nausea started to wane, coughing, sneezing and fatigue. I took a home COVID-19 test that came back positive, called my doctor and had a telehealth visit. She prescribed Paxlovid that I started immediately. I did get the weird taste my mouth, but I started feeling better in a few days. By September I started to feel like myself.
Lost consciousness for about 10 seconds immediately after injection and slid down in chair, extremities stiff Within 10 seconds, child became alert and was pale and diaphoretic. asking what had happened. Child eased to floor in lying position to recover, mother present. Drank some water and eager to leave. Walked out of clinic at 2:40 PM.
I'm still feeling so sick; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (I'm still feeling so sick) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (I'm still feeling so sick). At the time of the report, ILLNESS (I'm still feeling so sick) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  Concomitant product use was not provided by the reporter.  Treatment medication use was not provided by the reporter.
Seizure, patient fell to tile unconscious for about 45 seconds, was unaware of surroundings for about 1-2 minutes after waking up.  She injured her chin and broke 2 teeth during the fall.  In the ER, she had another short episode but the x-ray tech was able to catch her before she fell.
The patient complains of a rash that developed on her face 4 days after her vaccination.  She has tried to determine the cause outside of the vaccine,  but has been unsuccessful. She has tried treating the rash with diphenhydramine with no effect. The patient tried a topical steroid that helped but did not resolve the rash. The patient  is going to visit her Dr to follow up and possibly get an oral steroid.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was provided regarding the patient's past medical history, concurrent condition, or concomitant medication. The patient was inoculated with ZOSTAVAX vaccine (lot number not reported) on or about 18-JUL-2012 at a pharmacy as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 14-FEB-2016, the patient was treated by a nurse practitioner for a painful vesicular rash that was diagnosed as shingles. The patient was prescribed acyclovir and methylprednisolone, and  hydrocodone-acetaminophen   to manage her discomfort and  symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the shingles is unknown. Additional information has been requested.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71-year-old female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 14Sep2023 as dose number unknown, single (Batch/Lot number: unknown) at the age of 71 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Autoimmune disorders" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Iodine, reaction(s): "Known allergies: Iodine". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Sep2023, outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive; negative. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: Patient received COVID 19 anti viral treatment with Anti viral from 30Sep2023 to 05Oct2023. The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
HYPOXIA 12/12/2022 -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
While the vaccine was going in my arm it was stinging and burning. I fainted about 30 seconds after the injection. I waited at my vaccination site for about 30 minutes after that. My vision was blurring and turning black and white and my hearing went out. I felt lightheaded and fainted for a few seconds. Afterwards, I was lightheaded for quite some time and my blood pressure was a bit low.
I received my first vaccine May 11 and a week later I started having ringing in my ears along with pressure and pain. I saw my primary doctor, a walk in doctor, and finally an ENT for it.  I was afraid to get my 2nd dose but I went ahead with it and I still have ringing in both of my ears.
Hypopigmented contrast live push on left neck with severe slot on face.  Cipcucar and Rancau from 1 to 3 to arm.
experienced hives after receiving the first dose of GARDASIL 9; Information was received from a physician  via a field representative, referring to a 13 years old female patient. The patient's medical history, concurrent condition and concomitant medications were not provided.  On an unknown date, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (dose, strength, route, lot#, expiration date were unknown) for prophylaxis.  On an unknown date, the patient experienced hives. The patient was given diphenhydramine hydrochloride (BENADRYL) for hives. The outcome of the event was recovered. The causality was not reported by the reporter.
Suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (had 1st episode on an unknown date).   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were reported as follows: The patient self reported the case. The age at vaccination was not reported. The patient had the vaccines 2 doses and it did not prevent me from getting Shingles. The patient added that, this was the 2nd time, he/she experienced shingles. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization for shingles, time to onset for event and laboratory confirmation for herpes zoster were not provided.
patient reported feeling lightheaded and nauseous, having several dry heaves but not producing vomit
Acute fatigue, muscle and joint pains that lasted about 24 hours. Required only extended bedrest.
Pt had a c/o feeling as though she were going to pass out as she was checking out with secretaries.  Secretary called M.A. and they assisted Pt to sitting in chair.  MA got me to check Pt.  Pt stated she felt like she was going to pass out, had blurry vision, tingling to hands and ringing in her ears.  BP 92/54, R 18, P 78 weak, Pt stated she felt clammy, Pt too weak to transfer to w/c -> exam room at that time.  Color slightly pale.  BP 96/60, P62.  After sitting up 10" BP 98/62, P62, R-15 10" later BP 98/62 P60.  Standing BP98/60 P60 R-15 color improved, clammy feeling gone, Pt stated she thinks it was made worse by becoming frightened by Sx's.  Pt released to home once WNL- baseline.
Positive covid; Vaccinated with Sputnik, Moderna, Pfizer; Vaccinated with Sputnik, Moderna, Pfizer; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Positive covid), COVID-19 IMMUNISATION (Vaccinated with Sputnik, Moderna, Pfizer) and INTERCHANGE OF VACCINE PRODUCTS (Vaccinated with Sputnik, Moderna, Pfizer) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect products included non-company products TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication and COVID-19 VACCINE NRVV AD26 (GAM-COVID-VAC), COVID-19 VACCINE NRVV AD5 (GAM-COVID-VAC) (SPUTNIK V) for an unknown indication.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form, dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form and dose of COVID-19 VACCINE NRVV AD26 (GAM-COVID-VAC), COVID-19 VACCINE NRVV AD5 (GAM-COVID-VAC) (SPUTNIK V) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Positive covid), COVID-19 IMMUNISATION (Vaccinated with Sputnik, Moderna, Pfizer) and INTERCHANGE OF VACCINE PRODUCTS (Vaccinated with Sputnik, Moderna, Pfizer). At the time of the report, COVID-19 (Positive covid), COVID-19 IMMUNISATION (Vaccinated with Sputnik, Moderna, Pfizer) and INTERCHANGE OF VACCINE PRODUCTS (Vaccinated with Sputnik, Moderna, Pfizer) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant medications were not reported.  Patient was vaccinated with Sputnik, Moderna and Pfizer COVID-19 vaccine. Patient got positive with COVID-19.  Treatment information was not provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Could not get out of bed; pain all over his body, torso is hurting and the pain is constant with intermittent stabbing pains; headache; shivering; Ear pain; Thigh pain; Not feel well; pain at all three sights; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 66-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2019-2020 season) for prophylaxis and DTPa (Reduced antigen) (Tdap Vaccine) for prophylaxis.   On 10th January 2020, the patient received the 1st dose of Shingrix (intramuscular), Influenza vaccine Quadrivalent 2019-2020 season (intramuscular) and Tdap Vaccine (intramuscular). On 11th January 2020, 1 days after receiving Shingrix, Influenza vaccine Quadrivalent 2019-2020 season and Tdap Vaccine, the patient experienced injection site pain. On 19th January 2020, the patient experienced feeling unwell, general body pain, headache, shivering, ear pain and pain in thigh. On 20th January 2020, the patient experienced bedridden. The patient was treated with antihistamine, muscle relaxants (Muscle Relaxant) and ketorolac trometamol (Toradol). On an unknown date, the outcome of the injection site pain, headache and shivering were recovering/resolving and the outcome of the feeling unwell and bedridden were unknown and the outcome of the general body pain, ear pain and pain in thigh were not recovered/not resolved.   Additional details were received as follows: The case was reported by patient's wife. The reporter stated that the patient after the day of vaccinations experienced pain at all three sights. The patient started to not feel well and by January 20 he could not get out of bed. The pain was bearable so he got up to eat then went back to bed and had pain all over his body. The patient torso was hurting and the pain was constant with intermittent stabbing pains. The patient had pain behind his left ear and inside his left thigh. The patient also suffered from headaches, a few times with shivering but has not had any fever. The patient had been to his family doctor, the Urgent Care and the emergency room where he was for several hours. The reporter consented to follow up. It was unknown if the reporter considered the injection site pain, feeling unwell, bedridden, general body pain, headache, shivering, ear pain and pain in thigh to be related to Shingrix, Influenza vaccine Quadrivalent 2019-2020 season and Tdap Vaccine.
Death approx 6 to 7 hrs after vaccine administration. The death certificate state cardiopulmonary arrest and CAD.
Had mild-mod Covid Arm for a few days after shot, then everything was fine.  But on the ninth day, my arm symptoms of redness, swelling, soreness and especially itchiness came on with a vengeance; triple the prior symptoms right after the injection.  So it?s 2 weeks today since my injection, and for the last 6 days, including today, my arm has had a repeat of Covid Arm much worse  (@3x) than the initial symptoms.
I started experiencing bloody noses and welts and itchiness about a day after the shot. My left arm was sore as well, but what was bad was I started feeling inflammation of left arm, heart and head. It was low at first and actually helped with sleep the first day or two, but increased day by day, little by little. After a few days, it started affecting my sleep and the inflammation continued to trend worse each day. I had a real bad experience with a hospital prior to the pandemic, and came to the conclusion doctors there would not be able to help with something like this. Plus, it was in the middle of the pandemic and I didn't want to go to a hospital. I read a lot, took vitamins, and start fasting and using hot/cold therapies at home. The hot/cold therapies weren't that helpful, but I noticed a difference with the fasting. I knew my knees would hate longer fasts (did a 3 day one before--brain loved it, knees hated it). I noticed that after the first 30+ hours fast, the inflammation seemed a little better, but would increase again slowly so I fasted every week for 3+ months until the inflammation of heart and head felt under control. I know I should have reported this earlier and I actually downloaded the form, but got sidetracked. I want to report this in case it helps someone. Many of us experiencing adverse events aren't in the mood to fill out forms, especially while the event is occuring.  Some of us also needed time to process. I never went back for another shot. To this day, just the thought of another Covid shot makes my left arm hurt.
Patient developed severe 8/10 chest pain 2 days after the 2nd COVID Pfizer vaccine. Troponin elevated 4. Cardiac MRI was consistent with myocarditis. Echo is normal.
Reactions; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Reactions) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 12-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced VACCINATION COMPLICATION (Reactions). At the time of the report, VACCINATION COMPLICATION (Reactions) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
20 minutes after receiving vaccine, patient is assisted by caregiver to the entrance. On the way, he reports feeling dizzy and falls backward. He has no serious injuries. His ankle appears swollen and at an odd angle but he reports no pain. His caregiver decided to take him home.
Injection site erythema, induration and discomfort within 12-18 hr. after PNEUMOVAX.
I woke up at 4am with a racing heart, exhaustion, and severe heart palpitations. This was 3 months ago and I'm still experiencing heart palpitations daily. I can't exert myself, carry heavy things, walk long distances, or be in heat without feeling as though my heart is swollen/racing/palpitating. I went to the cardiologist and told her my symptoms and she said it is likely myocarditis.
Needle retracted from left arm following vaccine administration. Some vaccine ran down client's arm. Second dose was administered in right arm
Chest tightness; Shortness of breath; A spontaneous report was received from a consumer, concerning a 68 Years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced chest discomfort and dyspnea.  The patient's medical history was not provided. Concomitant medication includes Hydrochlorthiazide 12.5 mg daily for an unknown indication.  On 02 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: O25620A) for prophylaxis of COVID-19 infection.  On 18 Jan 2021, The patient experienced chest tightness and shortness of breath.  No treatment information was provided.   Action taken with mRNA-1273 in response to the events were not reported.   On 20 Jan 2021, the outcome of the events was resolved.; Reporter's Comments: This case concerns a 68-year-old, female patient. The patient's medical history was not provided. The patient experienced unexpected event of chest discomfort and dyspnea 17 days after the first dose of mRNA-1273 (lot/batch: O25620A) was administered. No treatment information was provided. Very limited information regarding this event has been provided at this time.  Based on temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Additional information has been requested.
This spontaneous report was received from a physician referring to multiple unspecified patients of unknown age and gender. The patient's pertinent medical history, concurrent conditions or concomitant medications were not reported. On multiple unspecified dates, the patients were vaccinated with improperly stored doses of ROTATEQ orally (lot#, dose, and frequency were unspecified) for prophylaxis. Concomitant therapies included sterile diluent (MERCK STERILE DILUENT). No adverse effects reported. No product quality complaint was involved. The vaccines were exposed to a temperature excursion of 51 Fahrenheit degrees for a time frame of 1.5 hours, identified because of a digital data logger. There was no previous temperature excursion. This is one of several reports from the same reporter.; Sender's Comments: US-009507513-1709USA007978: US-009507513-1709USA008156: US-009507513-1709USA008154:
10/01/21 patient presents with shortness of breath, hypoxia. States her oxygen at home was 85% on RA.  Pt admitted for 3 days for covid. Pt tested positive for covid. Had booster last week but her grandson was sick last week. Pt tested positive 9/23/21. Reports chronic diarrhea, shortness of breath, cough ,fever.  She did not receive decadron or remdesivir.